Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/29805

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorWang, Yan-Donges
dc.contributor.authorChen, Wei-Donges
dc.contributor.authorHuang, Wendong-
dc.date.accessioned2013-01-22T10:01:08Z-
dc.date.available2013-01-22T10:01:08Z-
dc.date.issued2008-
dc.identifier.issn0213-3911es
dc.identifier.urihttp://hdl.handle.net/10201/29805-
dc.description.abstractGreat progress has been made in the understanding of the physiological roles of the nuclear receptor farnesoid X receptor (FXR) during the last several years. Roles for FXR were initially identified in the regulation of bile acid, cholesterol, triglyceride, and glucose metabolism. More recently, our group has identified additional functional roles of FXR. Specifically, we have shown that FXR regulates normal liver regeneration and plays a protective role in liver carcinogenesis. These exciting findings suggest that FXR has a broader role than previously thought, and also highlight potential new opportunities for using FXR as a drug target for different diseases. Here we summarize the latest results from studies on FXR response elements, target genes and functions in different diseases.es
dc.formatapplication/pdfes
dc.format.extent7es
dc.languageenges
dc.publisherMurcia : F. Hernándezes
dc.relation.ispartofHistology and histopathologyes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectBile acides
dc.subjectMetabolismes
dc.subject.other575 - Genética general. Citogenética general. Inmunogenética. Evolución. Filogeniaes
dc.titleFXR, a target for different diseaseses
dc.typeinfo:eu-repo/semantics/articlees
Aparece en las colecciones:Vol.23, nº5 (2008)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
FXR, a target for different diseases.pdf1,48 MBAdobe PDFVista previa
Visualizar/Abrir


Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.